Berlin (ots) - Cannovum Health GmbH celebrates a key milestone in its corporate development: Triple Crown Ventures becomes the new majority investor. With this step, the company gains a financially strong and strategic partner who firmly believes in ...To the press release of Cannovum Health GmbH

Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona ...To the press release of Healthcare Holding Schweiz AG

Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic ...To the press release of CROMA-PHARMA GmbH

Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the ...To the press release of Syntellix AG

Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the ...To the press release of ABDA Bundesvgg. Dt. Apothekerverbände

Paris (ots/PRNewswire) - After two years of co-development marked by close collaboration, Groupement Hospitalier Loos Haubourdin (GHLH) has renewed its trust in Intalio, a recognized leader in digital transformation for organizations, by officially ...To the press release of Intalio, Inc.

Berlin (ots) - Registration for the World Health Summit 2025 is now open. From October 12-14, Berlin will once again host one of the most important strategic global health gatherings worldwide. Under the theme "Taking Responsibility for Health in a ...To the press release of World Health Summit

New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark ...To the press release of Ichnos Glenmark Innovation

New York (ots) - 47-Ingredient Formula Targets Workplace Stress and Mental Fatigue in High-Performance Workers Axolt announced the launch of its revolutionary brain health supplement designed specifically for high-performing professionals ...To the press release of Axolt

Sunnyvale, California (ots) - Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use ...To the press release of Intuitive Surgical Deutschland GmbH

Vienna/Zell am See (ots) - “Anyone visiting somebody in a hospital must disinfect their hands,” says the long-standing advisor to the World Health Organization – Pittet to visit Austria on June 26, 2025 “It takes 20 seconds – and in those ...To the press release of Hagleitner Hygiene International GmbH

Petach Tikva, Israel (ots/PRNewswire) - Strategic appointments reflect Medison's continued investment in global scale and operational excellence Medison, the creator of a first-of-its-kind unified global commercialization platform that accelerates ...To the press release of Medison Pharma

London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has ...To the press release of Isomorphic Labs

Tel Aviv, Israel (ots/PRNewswire) - MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device ...To the press release of MedHub; Terumo

Munich (ots/PRNewswire) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing ...To the press release of Innovative Molecules GmbH

Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Ino Medical Solutions GmbH. Healthcare ...To the press release of Healthcare Holding Schweiz AG

Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at ...To the press release of BIAL SA

Aachen, Germany (ots) - - Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America. - As part of the ...To the press release of Grünenthal Group

Petach Tikva, Israel (ots/PRNewswire) - ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing ...To the press release of Isotopia Molecular Imaging

Petah Tikva, Israel (ots/PRNewswire) - Isotopia Molecular Imaging, in partnership with Cardirad , proudly announces the launch of Isoprotrace®—an advanced Gallium-68 Gozetotide preparation kit for prostate cancer imaging—in Sweden and Denmark. ...To the press release of Isotopia Molecular Imaging

Brussels (ots) - In the lead-up to World No Tobacco Day 2025 on 31 May, the Independent European Vape Alliance (IEVA) highlights compelling evidence that the majority of e-cigarette users in Europe are former smokers. This underscores the important ...To the press release of IEVA (Independent European Vape Alliance)

Berlin/Copenhagen (ots) - x-cardiac GmbH, a leading provider of AI-based health solutions and a spin-off of the German Heart Center of Charité and Charité - Universitätsmedizin Berlin, announced today a strategic distribution partnership with the ...To the press release of x-cardiac GmbH

Aachen (ots) - Maren Thurow has today assumed the role of Vice President and Head Global Communications at Grünenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company’s Communications department since 2021. In ...To the press release of Grünenthal Group

Heidelberg, Germany, Milan, Seville, Spain and Binyamina, Israel (ots/PRNewswire) - A European-led consortium comprising Heidelberg University Hospital (UKHD), the European Institute of Oncology (IEO), Virgen Macarena University Hospital, and ...To the press release of NeutroFlow

Vienna, Austria (ots) - Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing ...To the press release of Biomay AG

Lübeck/Amman (ots) - A Lübeck Campus Hearing Acoustics team of experts took part in the 11th Arab Hearing Health Conference (AHH 2025) organized by the Advanced Arab Academy of Audiovestibular, held in Amman, Jordan, from April 24 to 26, 2025. ...To the press release of Bundesinnung der Hörakustiker KdöR

Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Aestheticbedarf AG. Healthcare Holding ...To the press release of Healthcare Holding Schweiz AG

Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio by acquiring CDP Swiss AG and CDP Austria GmbH. Healthcare Holding ...To the press release of Healthcare Holding Schweiz AG

Vienna (ots) - The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of ...To the press release of Biomay AG

Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced ...To the press release of Acousia Therapeutics GmbH